Citations

Showing 10 of 108094 citations.

Genome Projects and Gene Therapy: Gateways to Next Generation Biological Weapons
Black, John L.

Mayo Clinic

Military Medicine | February 28, 2018 | Volume: 168 | Issue: 11 | Pages: 864-871

10.1093/milmed/168.11.864 Get It

Pharmacological assessment of the contribution of the arterial baroreflex to sympathetic discharge patterns in healthy humans
Limberg, Jacqueline K. , Ott, Elizabeth P., Holbein, Walter W., Baker, Sarah E. , Curry, Timothy B. , Nicholson, Wayne T. , Shoemaker, J. Kevin , Shoemaker, J Kevin , Joyner, Michael J. , Baker, Sarah E

Mayo Clinic

Journal of Neurophysiology | February 28, 2018 | Volume: 119 | Issue: 6 | Pages: 2166-2175

10.1152/jn.00935.2017 | PMID 29488839 Get It

To study how changes in baroreceptor afferent activity affect patterns of sympathetic neural activation, we manipulated arterial blood pressure with intravenous nitroprusside (NTP) and phenylephrine (PE) and measured action potential (AP) patterns with wavelet-based methodology. We hypothesized that 1) baroreflex unloading (NTP) would increase firing of low-threshold axons and recruitment of latent axons and 2) baroreflex loading (PE) would decrease firing of low-threshold axons. Heart rate (HR, ECG), arterial blood pressure (BP, brachial catheter), and muscle sympathetic nerve activity (MSNA, microneurography of peroneal nerve) were measured at baseline and during steady-state systemic, intravenous NTP (0.5–1.2 µg·kg−1·min−1, n = 13) or PE (0.2–1.0 µg·kg−1·min−1, n = 9) infusion. BP decreased and HR and integrated MSNA increased with NTP ( P < 0.01). AP incidence (326 ± 66 to 579 ± 129 APs/100 heartbeats) and AP content per integrated burst (8 ± 1 to 11 ± 2 APs/burst) increased with NTP ( P < 0.05). The firing probability of low-threshold axons increased with NTP, and recruitment of high-threshold axons was observed (22 ± 3 to 24 ± 3 max cluster number, 9 ± 1 to 11 ± 1 clusters/burst; P < 0.05). BP increased and HR and integrated MSNA decreased with PE ( P < 0.05). PE decreased AP incidence (406 ± 128 to 166 ± 42 APs/100 heartbeats) and resulted in fewer unique clusters (15 ± 2 to 9 ± 1 max cluster number, P < 0.05); components of an integrated burst (APs or clusters per burst) were not altered ( P > 0.05). These data support a hierarchical pattern of sympathetic neural activation during manipulation of baroreceptor afferent activity, with rate coding of active neurons playing the predominant role and recruitment/derecruitment of higher-threshold units occurring with steady-state hypotensive stress. NEW & NOTEWORTHY To study how changes in baroreceptor afferent activity affect patterns of sympathetic neural activation, we manipulated arterial blood pressure with intravenous nitroprusside and phenylephrine and measured sympathetic outflow with wavelet-based methodology. Baroreflex unloading increased sympathetic activity by increasing firing probability of low-threshold axons (rate coding) and recruiting new populations of high-threshold axons. Baroreflex loading decreased sympathetic activity by decreasing the firing probability of larger axons (derecruitment); however, the components of an integrated burst were unaffected.
The use of cytapheresis in the treatment of infectious diseases
Norgan, Andrew P. , Pritt, Bobbi S. , Winters, Jeffrey L , Pritt, Bobbi S , Juskewitch, Justin E. , Winters, Jeffrey L. , Norgan, Andrew P

Mayo Clinic

Journal of Clinical Apheresis | February 28, 2018 | Volume: 33 | Issue: 4 | Pages: 529-537

10.1002/jca.21620 | PMID 29488237 Get It

Cytapheresis (removal of cellular blood components) has been employed for treatment of infectious diseases since the 1960s. Techniques have included thrombocytapheresis (buffy coat apheresis) for loiasis, erythrocytapheresis for malaria and babesiosis, and leukocytapheresis for pertussis‐associated lymphocytosis. Published data on these applications is largely limited to case level data and small observational studies; as such, recommendations for or against the use of cytapheresis in the treatment of infections have been extrapolated from these limited (and at times flawed) data sets. Consequently, utilization of cytapheresis in many instances is not uniform between institutions, and typically occurs at the discretion of treating medical teams. This review revisits the existing literature on the use of cytapheresis in the treatment of four infections (loasis, malaria, babesiosis, and pertussis) and examines the rationale underlying current treatment recommendations concerning its use.
Use of the CRISPR/Cas9‐based epigenetic gene activation system In Vivo: A new potential therapeutic modality
Ibrahim, Samar H. , Robertson, Keith D. , Robertson, Keith D , Ibrahim, Samar H

Mayo Clinic

Hepatology | February 28, 2018 | Volume: 68 | Issue: 3 | Pages: 1191-1193

10.1002/hep.29860 | PMID 29489018 Get It

Allelic variant in the glucagon‐like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
Chedid, Victor , Vijayvargiya, Prakhar , Carlson, Paula, Malderen, Kathleen Van , Zinsmeister, Alan R., Camilleri, Michael , Camilleri, M , Chedid, Victor G , Acosta, Andrés

Mayo Clinic

Neurogastroenterology & Motility | February 28, 2018 | Volume: 30 | Issue: 7 | Pages: No page available

10.1111/nmo.13313 | PMID 29488276 Get It

AbstractBackgroundWeight loss in response to the long‐acting GLP‐1 receptor (GLP1R) analog, liraglutide, is correlated with delay in gastric‐emptying (GE). The aim of this pilot study was to assess whether specific genetic variants in GLP1R or TCF7L2 are associated with delayed GE and weight loss in obese patients treated with liraglutide or the short‐acting GLP‐1 agonist, exenatide.MethodsWe evaluated in obese individuals the associations of genetic variations of GLP1R (rs6923761) and TCF7L2 (rs7903146) on GE T1/2 and weight from two trials that evaluated separately exenatide, 5 μg BID for 30 days, or liraglutide, 3 mg daily for 5 weeks. Data were analyzed using the dominant genetic model and intention‐to‐treat analysis.Key ResultsThere was a significant correlation between changes in weight and GE T1/2 (rs = −.382, P = .004). GLP1R rs6923761 minor allele A (AA_AG) carriers who received either exenatide or liraglutide had greater delay in GE T1/2 relative to baseline (117.9 ± 27.5 [SEM] minutes and 128.9 ± 38.32 minutes) compared to GG genotype (95.8 ± 30.4 minutes and 61.4 ± 21.4 minutes, respectively; P = .11). There was a non‐significant difference in weight loss based on GLP1R rs6923761 genotype after 5 weeks of treatment. There were no significant correlations with TCF7L2 (rs7903146) genotype.Conclusions & InferencesThe minor A allele of GLP1R (rs6923761) is associated with greater delay in GE T1/2 in response to liraglutide and exenatide. These studies provide data to plan pharmacogenetics testing of the hypothesis that GLP1R (rs6923761) influences weight loss in response to GLP1R agonists.
Pharmacologic and Perioperative Considerations for Antihypertensive Medications
Pai, Sher‐Lu , Irizarry-Alvarado, Joan M., Aniskevich, Stephen , Renew, Johnathan Ross, Pai, Sher-Lu , Aniskevich, Stephen , Chadha, Ryan , Renew, J. Ross

Mayo Clinic

Current Clinical Pharmacology | February 28, 2018 | Volume: 12 | Issue: 3 | Pages: 135-140

10.2174/1574884712666170918152004 | PMID 28925860 Get It

Time‐resolved contrast‐enhanced MR angiography with single‐echo Dixon fat suppression
Stinson, Eric G. , Trzasko, Joshua D. , Glockner, James F., Young, Phillip M. , Riederer, Stephen J. , Campeau, Norbert G. , Huston, John

Mayo Clinic

Magnetic Resonance in Medicine | February 28, 2018 | Volume: 80 | Issue: 4 | Pages: 1556-1567

10.1002/mrm.27152 | PMID 29488251 Get It

PurposeDixon‐based fat suppression has recently gained interest for dynamic contrast‐enhanced MRI, but multi‐echo techniques require longer scan times and reduce temporal resolution compared to single‐echo alternatives without fat suppression. The purpose of this work is to demonstrate accelerated single‐echo Dixon imaging with high spatial and temporal resolution.Theory and MethodsReal‐valued water and fat images can be obtained from a single measurement if the shared initial phase and that due to are assumed known a priori. An expression for simultaneous sensitivity encoding (SENSE) unfolding and fat‐water separation is derived for the general undersampling case, and simplified under the special case of uniform Cartesian undersampling. In vivo experiments were performed in extremities and brain with SENSE acceleration factors of up to R = 8.ResultsSingle‐echo Dixon reconstruction of highly undersampled data was successfully demonstrated. Dynamic contrast‐enhanced water and fat images provided high spatial and temporal resolution dynamic images with image update times shorter than previous single‐echo Dixon work.ConclusionTime‐resolved contrast‐enhanced MRI with single‐echo Dixon fat suppression shows high image quality, improved vessel delineation, and reduced sensitivity to motion when compared to time‐subtraction methods.
Treatment of acute exacerbations of interstitial lung disease
Azadeh, Natalya , Moua, Teng , Baqir, Misbah , Ryu, Jay H. , Ryu, Jay H

Mayo Clinic

Expert Review of Respiratory Medicine | February 27, 2018 | Volume: 12 | Issue: 4 | Pages: 309-313

10.1080/17476348.2018.1446831 | PMID 29486130 Get It

Reverse shoulder arthroplasty for the treatment of acute complex proximal humeral fractures: Influence of greater tuberosity healing on the functional outcomes
Mingo, Felipe, Gamba, Carlo , Santana, Fernando , Alentorn-Geli, Eduard, Gamba, Carlo , Torrens, Carlos , Alentorn‐Geli, Eduard

Mayo Clinic

Journal of Orthopaedic Surgery | February 27, 2018 | Volume: 26 | Issue: 1 | Pages: No page available

10.1177/2309499018760132 | PMID 29486672 Get It

Purpose: To investigate the influence of greater tuberosity healing on the functional outcomes of reverse shoulder arthroplasty (RSA) for the treatment of acute complex proximal humeral fractures (PHFs), and to investigate the influence of patient- and surgery-related factors in the healing of the greater tuberosity. Methods: Retrospective study including 41 consecutive PHFs treated using RSA with minimum 2-year follow-up. In all the cases, tuberosities were reattached with a standardized technique. All the patients were assessed at the last follow-up with constant score. Body mass index, surgery delay, comorbidities, polyethylene size, glenosphere size, overhanging of glenosphere, and scapular notch were recorded, and their influence in final constant score and in greater tuberosity healing was analyzed. Results: Mean final constant score was of 60.7 points (standard deviation (SD) = 9.9). Greater tuberosity healed in proper position in 68% of the cases. There were no significant differences in constant score between patients with (mean = 61; SD = 9.5) and without (mean = 61; SD = 11.3) the healing of greater tuberosity. All patients scored above 90° in forward elevation. Scapular notch was reported in 14.6% of the cases. Age significantly affected the constant score ( p = 0.008). Comorbidities significantly interfered with greater tuberosity healing ( p = 0.03). There was one reoperation after dislocation. Conclusion: In spite of expecting good functional outcome with low complication rate after RSA for acute PHFs, the influence of greater tuberosity healing on shoulder function could not be demonstrated. The presence of comorbidities, but not age or gender, negatively influenced the healing of the greater tuberosity.